News
You are here: Home1 / Uncategorized2 / MPN Education Morning & webinar – PeterMac – 18 February 2020
MPN Alliance Australia Newsletter
Fedratinib available for myelofibrosis patients?
Call for submissions
The Pharmaceutical Benefits Advisory Committee is open for comments from patients about the possible inclusion of Fedratinib (Inrebic ®) onto the PBS for eligible MF patients.
CLOSING DATE 26 MARCH 2025 - see HERE!